Almost 400 medications are currently in short supply in Switzerland. Pharmacists are sounding the alarm.
This content was published on
2 minutes
SRF-RTS/ln
Ibuprofen drugs, the popular heart medication Aspirin Cardio and the asthma spray Ventolin are currently no longer being delivered to Switzerland and the pharmacies are running short on supplies, reported Swiss public television, SRF, on Tuesday.
Hospital pharmacist Enea Martinella said doctors and patients must prepare for the worst-case scenario – switching to a different active ingredient.
But substituting drugs because they are no longer available would have a whole host of negative consequences, Martinella warned in an interview with SRF.
“It would lead to significantly more visits to the doctor and higher costs,” he said. “Record after record is being broken.”
The pharmacists’ national shortage list for which Martinella is responsible currently contains 388 medications that are difficult to obtain.
The federal short-supply list of important painkillers, antibiotics and vaccines is shorter.
Ueli Haudenschild of the Federal Office of Economic Supply said the trend towards a national medication shortage has been ongoing for the past two years.
While the current situation did not represent a peak, it was “problematic that important products are permanently unavailable”, he said.
Of particular concern was the lack of individual active ingredients when it came to antibiotics, which was the case 20 times last year alone, he said.
The reason for the lack of certain ingredients is that they are being manufactured in just a few manufacturing plants in the world.
If a fire or tornado affects those factories, as happened two years ago in China and Puerto Rico, the whole pharmacological industry is affected, said Haudenschild.
More
More
What’s behind Switzerland’s vaccine shortage?
This content was published on
Switzerland is struggling to maintain stocks of 16 key vaccines, forcing doctors to adapt their practices.
Swiss money laundering office registers record number of reports
This content was published on
The Money Laundering Reporting Office Switzerland (MROS) registered a record number of reports of suspicious activity last year.
Two teens accused of planning terror attack released from custody
This content was published on
The Schaffhausen judiciary has released the two teenagers from custody who allegedly planned bomb attacks in Switzerland.
OECD: Sluggish economic activity slowing growth in Switzerland
This content was published on
Sluggish economic activity at the start of the year is weighing on growth in Switzerland, with GDP expected to fall to 1.1% in 2024.
Report finds mistakes which led to Swiss government data breach
This content was published on
Mistakes were made by both the government and internet company Xplain in the case of a criminal cyber-attack on the Bern-based IT business.
Swiss government wants better gender balance in federal administration
This content was published on
New Swiss government personnel management targets say there must be even more female managers in the federal administration.
Swiss national science foundation funded over 5,000 projects in 2023
This content was published on
In 2023, the Swiss National Science Foundation (SNSF) provided a total of CHF961 million worth of funding towards research projects.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Opioid painkiller prescriptions surge in Switzerland
This content was published on
Prescription for powerful opioid medication have increased twenty-fold in the last thirty years, a recent study has found.
From drugs to food: delivering sensitive goods safely
This content was published on
Swiss high-tech firm Smart Containers employs sensors and blockchain to ensure the safe delivery of medicines - and now perishable food.
No cannabis for scientific studies, says parliament
This content was published on
The Swiss parliament has rejected a motion to allow the use of cannabis in scientific studies investigating the drug’s effects.
Generic drugs in Switzerland cost twice as much as in Europe
This content was published on
The price of generic drugs in Switzerland in 2017 was 52% higher than the average of nine other European countries, says a study.
Swiss campaign to make lifesaving drugs affordable
This content was published on
Swiss authorities must act to make lifesaving drugs more affordable by introducing compulsory licensing, says NGO Public Eye.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.